Back to Library
Specialist Review

Fetal Therapy & Procedures

Multifetal Pregnancy Reduction

Clinical review of this update pending
4 min read
Editorial update: 2026-10-20
High-order MultiplesTarget
11–13 WeeksTiming
Needle-guidedProcedure
Twin/Singleton SurvivalGoal

In brief — the direct answer

Multifetal Pregnancy Reduction (MFPR) is a medical procedure offered to families with high-order multiple pregnancies (triplets, quadruplets, or more). While the idea of multiple babies is often a joy, carrying three or more fetuses carries extreme risks, including very early premature birth, cerebral palsy, and maternal complications like pre-eclampsia. By reducing the number of fetuses to two (twins) or one (singleton), we significantly increase the chances that the remaining babies will be born healthy and at a safe gestational age.

What is Multifetal Pregnancy Reduction?

The procedure is performed early in the pregnancy, typically between 11 and 13 weeks.

For pregnancies where each baby has its own placenta (dichorionic/trichorionic), the procedure involves a thin needle guided by ultrasound to deliver a small amount of medication (potassium chloride) to the heart of the selected fetus. The baby's heart stops quickly and painlessly. The remaining fetuses then continue to develop normally with significantly reduced risks of prematurity.

Who is at risk?

MFPR is considered for:

  • Triplets or more: To reduce the risk of extreme prematurity (birth before 28 weeks).
  • High-Risk Mothers: Women with a history of cervical weakness or prior premature births where a triplet pregnancy would be physically dangerous.
  • Structural Anomalies: If one baby in a triplet set is found to have a severe defect, 'selective' reduction of that specific baby can be performed.

How we diagnose it

Before any decision, assess chorionicity, anatomy and available genetic information, and discuss the options, timing and uncertainty with a specialist team. Counselling should be non-directive and include the option of continuing the pregnancy. The procedure, eligibility and local requirements need individual review; no assessment can identify a baby guaranteed to be healthy.

What does management involve?

The procedure is similar to a CVS or Amniocentesis:

  • Precision: The surgeon identifies the baby most accessible and further away from the others.
  • Speed: The actual reduction takes only a few minutes.
  • Recovery: The mother rests in our clinic for an hour and is then monitored with a follow-up scan a few days later.
  • The Future: The reduced fetus remains in the uterus and typically shrinks over time, having no impact on the birth of the healthy twins.

What are the outcomes?

Reducing the number of fetuses may reduce some risks of high-order pregnancy in selected circumstances, but carries a risk of loss of the entire pregnancy, membrane rupture and preterm birth. The balance differs by starting number, chorionicity, gestation and the planned remaining pregnancy. Compare applicable evidence and audited centre outcomes rather than assuming every reduction improves every outcome.

When to see a subspecialist

Deciding on MFPR is one of the most difficult decisions a family can face. It requires expert clinical guidance and the highest levels of technical skill.

At the MFM Unit, Dr. Leanne Bricker leads our multiple pregnancy service. We provide the compassionate counseling and the precise surgical care needed to ensure that your path forward is as safe and healthy as possible for both you and your babies.

Questions to ask your doctor

The risk of losing the entire pregnancy after reduction is about 4-5%. This must be weighed against the much higher risk (over 20%) of losing one or more babies due to extreme prematurity in triplet pregnancies.
Ideally between 11 and 12 weeks. This is late enough to ensure the twins are developing normally, but early enough for the procedure to be as safe as possible.
It is similar to a blood test or amniocentesis. A local anesthetic is used to numb the skin where the needle enters.
The fetus becomes a small piece of tissue that stays at the edge of the placenta. It is delivered silently alongside the healthy babies at birth.

References & Clinical Guidelines

  1. Updated Practice Guidelines: role of ultrasound in twin pregnancy — ISUOG (2025)
  2. Twin and triplet pregnancy (NG137; includes 2024 cervical-length/progesterone update) — NICE (2019; updated 2024)
Share this resource